Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.70 CNY | -1.09% |
|
-1.02% | -10.78% |
| Mar. 31 | Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025 | MT |
| Mar. 31 | Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20% | MT |
Business description: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Number of employees: 3,890
Sales by Activity: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Western Medicine | 1.6B | 1.78B | 1.7B | 1.19B | - |
Others | 627M | 796M | 673M | 443M | - |
Chinese Patent Medicine | 4.67B | 5.65B | 5.84B | 5.66B | - |
Geographical breakdown of sales: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Overseas | 33.91M | 33.74M | 44.88M | 36.73M | - |
China | 6.86B | 8.2B | 8.16B | 7.26B | - |
Executive Committee: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Composition of the Board of Directors: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
| Director | Title | Age | Since |
|---|---|---|---|
Guat Kwang Yeo
BRD | Director/Board Member | 65 | 2023-11-27 |
Yoke Pheng Liew
BRD | Director/Board Member | 70 | 2020-06-04 |
Hong Zhou
BRD | Director/Board Member | 56 | 2012-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
Lei Wang
CHM | Chairman | 55 | 2024-11-25 |
Ming Zhong
BRD | Director/Board Member | 39 | 2024-05-14 |
Min Guo
BRD | Director/Board Member | 55 | 2021-09-05 |
Wei Wen Mao
BRD | Director/Board Member | 52 | 2022-12-29 |
Ming Jie Shang
BRD | Director/Board Member | 57 | 2023-06-20 |
Company details: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Da Ren Tang Mansion
300193, Tianjin
+
http://www.jydrt.com.cn
Alternative Medicine
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.09% | -1.02% | +35.35% | +1.83% | 4.06B | ||
| -0.41% | +0.67% | -3.76% | -0.32% | 14.47B | ||
| -0.75% | -0.25% | -23.21% | -49.58% | 5.58B | ||
| -2.88% | -1.33% | -13.55% | +4.89% | 5.09B | ||
| -2.74% | -0.30% | +26.54% | -45.71% | 4.09B | ||
| -1.35% | -0.92% | -4.74% | -22.57% | 3.37B | ||
| -1.18% | +0.78% | -5.06% | -8.12% | 3.12B | ||
| -1.07% | -0.12% | +14.71% | -18.19% | 2.58B | ||
| -0.60% | -0.13% | -3.28% | -12.14% | 1.95B | ||
| -0.75% | -2.77% | -7.58% | +34.01% | 1.74B | ||
| Average | -1.28% | +0.79% | +1.54% | -11.59% | 4.6B | |
| Weighted average by Cap. | -1.17% | +0.78% | -0.31% | -11.92% |
Sector
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.70
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Select your edition
All financial news and data tailored to specific country editions

















